Literature DB >> 33386949

Classification of oligometastatic prostate cancer with additional consideration for hormone sensitivity.

Soichiro Yoshida1, Hisashi Matsushima2, Yasuhisa Fujii3.   

Abstract

Entities:  

Keywords:  Castration-resistant; Classification; Neoplasm metastasis; Prostatic neoplasms

Mesh：

Substances：

Year:  2021        PMID： 33386949     DOI： 10.1007/s00345-020-03570-9

Source DB:  PubMed          Journal:  World J Urol        ISSN： 0724-4983            Impact factor:   4.226


× No keyword cloud information.
  10 in total

1.  Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study.

Authors:  Luca Triggiani; Rosario Mazzola; Stefano Maria Magrini; Gianluca Ingrosso; Paolo Borghetti; Fabio Trippa; Andrea Lancia; Beatrice Detti; Giulio Francolini; Fabio Matrone; Roberto Bortolus; Giuseppe Fanetti; Ernesto Maranzano; Francesco Pasqualetti; Fabiola Paiar; Marco Lorenzo Bonù; Alessandro Magli; Alessio Bruni; Ercole Mazzeo; Ciro Franzese; Marta Scorsetti; Filippo Alongi; Barbara Alicja Jereczek-Fossa; Piet Ost; Michela Buglione
Journal:  World J Urol       Date:  2019-03-11       Impact factor: 4.226

2.  Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019.

Authors:  Silke Gillessen; Gerhardt Attard; Tomasz M Beer; Himisha Beltran; Anders Bjartell; Alberto Bossi; Alberto Briganti; Rob G Bristow; Kim N Chi; Noel Clarke; Ian D Davis; Johann de Bono; Charles G Drake; Ignacio Duran; Ros Eeles; Eleni Efstathiou; Christopher P Evans; Stefano Fanti; Felix Y Feng; Karim Fizazi; Mark Frydenberg; Martin Gleave; Susan Halabi; Axel Heidenreich; Daniel Heinrich; Celestia Tia S Higano; Michael S Hofman; Maha Hussain; Nicolas James; Ravindran Kanesvaran; Philip Kantoff; Raja B Khauli; Raya Leibowitz; Chris Logothetis; Fernando Maluf; Robin Millman; Alicia K Morgans; Michael J Morris; Nicolas Mottet; Hind Mrabti; Declan G Murphy; Vedang Murthy; William K Oh; Piet Ost; Joe M O'Sullivan; Anwar R Padhani; Chris Parker; Darren M C Poon; Colin C Pritchard; Robert E Reiter; Mack Roach; Mark Rubin; Charles J Ryan; Fred Saad; Juan Pablo Sade; Oliver Sartor; Howard I Scher; Neal Shore; Eric Small; Matthew Smith; Howard Soule; Cora N Sternberg; Thomas Steuber; Hiroyoshi Suzuki; Christopher Sweeney; Matthew R Sydes; Mary-Ellen Taplin; Bertrand Tombal; Levent Türkeri; Inge van Oort; Almudena Zapatero; Aurelius Omlin
Journal:  Eur Urol       Date:  2020-01-27       Impact factor: 20.096

3.  Progressive Site-Directed Therapy for Castration-Resistant Prostate Cancer: Localization of the Progressive Site as a Prognostic Factor.

Authors:  Soichiro Yoshida; Taro Takahara; Yuki Arita; Chikako Ishii; Yusuke Uchida; Keiko Nakagawa; Kazuma Toda; Tsuyoshi Sakamoto; Toshiki Kijima; Minato Yokoyama; Junichiro Ishioka; Yoh Matsuoka; Kazutaka Saito; Ryoichi Yoshimura; Yasuhisa Fujii
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-06-12       Impact factor: 7.038

4.  Oligometastases.

Authors:  S Hellman; R R Weichselbaum
Journal:  J Clin Oncol       Date:  1995-01       Impact factor: 44.544

5.  Carbon 11-choline positron emission tomography/computed tomography and palliative local therapy for castration-resistant prostate cancer.

Authors:  Keina Nozaki; Taketo Kawai; Tetsuya Fujimura; Hotaka Matsui; Taro Teshima; Takahiro Oshina; Atsuko Takahashi; Yusuke Sato; Daisuke Yamada; Takeshi Azuma; Masatoshi Hotta; Kazuhiko Nakajima; Hidetsugu Nakayama; Ryogo Minamimoto; Haruki Kume
Journal:  Int Urol Nephrol       Date:  2019-07-19       Impact factor: 2.370

Review 6.  EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.

Authors:  Nicolas Mottet; Roderick C N van den Bergh; Erik Briers; Thomas Van den Broeck; Marcus G Cumberbatch; Maria De Santis; Stefano Fanti; Nicola Fossati; Giorgio Gandaglia; Silke Gillessen; Nikos Grivas; Jeremy Grummet; Ann M Henry; Theodorus H van der Kwast; Thomas B Lam; Michael Lardas; Matthew Liew; Malcolm D Mason; Lisa Moris; Daniela E Oprea-Lager; Henk G van der Poel; Olivier Rouvière; Ivo G Schoots; Derya Tilki; Thomas Wiegel; Peter-Paul M Willemse; Philip Cornford
Journal:  Eur Urol       Date:  2020-11-07       Impact factor: 20.096

7.  Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial.

Authors:  Piet Ost; Dries Reynders; Karel Decaestecker; Valérie Fonteyne; Nicolaas Lumen; Aurélie De Bruycker; Bieke Lambert; Louke Delrue; Renée Bultijnck; Tom Claeys; Els Goetghebeur; Geert Villeirs; Kathia De Man; Filip Ameye; Ignace Billiet; Steven Joniau; Friedl Vanhaverbeke; Gert De Meerleer
Journal:  J Clin Oncol       Date:  2017-12-14       Impact factor: 44.544

Review 8.  Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation.

Authors:  Matthias Guckenberger; Yolande Lievens; Angelique B Bouma; Laurence Collette; Andre Dekker; Nandita M deSouza; Anne-Marie C Dingemans; Beatrice Fournier; Coen Hurkmans; Frédéric E Lecouvet; Icro Meattini; Alejandra Méndez Romero; Umberto Ricardi; Nicola S Russell; Daniel H Schanne; Marta Scorsetti; Bertrand Tombal; Dirk Verellen; Christine Verfaillie; Piet Ost
Journal:  Lancet Oncol       Date:  2020-01       Impact factor: 41.316

9.  Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial.

Authors:  Christopher C Parker; Nicholas D James; Christopher D Brawley; Noel W Clarke; Alex P Hoyle; Adnan Ali; Alastair W S Ritchie; Gerhardt Attard; Simon Chowdhury; William Cross; David P Dearnaley; Silke Gillessen; Clare Gilson; Robert J Jones; Ruth E Langley; Zafar I Malik; Malcolm D Mason; David Matheson; Robin Millman; J Martin Russell; George N Thalmann; Claire L Amos; Roberto Alonzi; Amit Bahl; Alison Birtle; Omar Din; Hassan Douis; Chinnamani Eswar; Joanna Gale; Melissa R Gannon; Sai Jonnada; Sara Khaksar; Jason F Lester; Joe M O'Sullivan; Omi A Parikh; Ian D Pedley; Delia M Pudney; Denise J Sheehan; Narayanan Nair Srihari; Anna T H Tran; Mahesh K B Parmar; Matthew R Sydes
Journal:  Lancet       Date:  2018-10-21       Impact factor: 79.321

10.  Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial.

Authors:  Ryan Phillips; William Yue Shi; Matthew Deek; Noura Radwan; Su Jin Lim; Emmanuel S Antonarakis; Steven P Rowe; Ashley E Ross; Michael A Gorin; Curtiland Deville; Stephen C Greco; Hailun Wang; Samuel R Denmeade; Channing J Paller; Shirl Dipasquale; Theodore L DeWeese; Daniel Y Song; Hao Wang; Michael A Carducci; Kenneth J Pienta; Martin G Pomper; Adam P Dicker; Mario A Eisenberger; Ash A Alizadeh; Maximilian Diehn; Phuoc T Tran
Journal:  JAMA Oncol       Date:  2020-05-01       Impact factor: 31.777
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.